ImmuCell Q4 EPS $(0.21) Down From $0.01 YoY, Sales $3.91M Down From $5.44M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.21) per share. This is a 2200 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $3.91 million in sales this